相关实验视频
Updated: Jul 18, 2025
08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.0K
为瘤学领域的个性化医疗建立健康经济框架的挑战和机遇
Pedro Nazareth Aguiar1,2, Silvio Matsas3, Rodrigo Dienstmann1
1Grupo Oncoclínicas, São Paulo, 04513-0202, Brazil.
Personalized medicine
|August 21, 2023
概括
个性化医疗改善了癌症护理,但高昂的成本限制了这一点,特别是在低收入国家. 需要全球合作来加强经济工具,并扩大患者获得这些先进治疗的机会.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 卫生经济学 卫生经济学
背景情况:
- 个性化医疗通过利用个人级别的数据来推进癌症的预防和治疗.
- 基因组测试和向治疗提供了显著的临床益处,但面临成本障碍.
研究的目的:
- 解决瘤学个性化医学的药物经济挑战.
- 探索改善全球获得个性化癌症护理的策略.
主要方法:
- 审查目前的瘤学个性化医疗应用.
- 对基因组测试和向治疗的成本效益和价值框架的分析.
- 对获得癌症护理的经济差异的评估.
主要成果:
- 个性化医疗改善了各种瘤的治疗结果.
- 基因组测试和向治疗的高成本限制了患者的获取,特别是在低收入和中等收入国家.
- 现有的价值框架和健康技术评估对个性化医疗药物经济提出了担忧.
结论:
- 全球合作对于完善个性化医疗的经济评估工具至关重要.
- 改善药物经济策略可以提高公平获得个性化癌症治疗的机会.
- 解决成本障碍对于实现全球瘤学个性化医学的全部潜力至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:29Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
01:21Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
01:30Cancer Vaccines
400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K